These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 17828469

  • 1. RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer.
    Clark JC, Thomas DM, Choong PF, Dass CR.
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):675-83. PubMed ID: 17828469
    [Abstract] [Full Text] [Related]

  • 2. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
    Takemoto N, Tada M, Hida Y, Asano T, Cheng S, Kuramae T, Hamada J, Miyamoto M, Kondo S, Moriuchi T.
    Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
    [Abstract] [Full Text] [Related]

  • 3. Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer.
    Takenaka K, Ishikawa S, Kawano Y, Yanagihara K, Miyahara R, Otake Y, Morioka Y, Takahashi C, Noda M, Wada H, Tanaka F.
    Eur J Cancer; 2004 Jul; 40(10):1617-23. PubMed ID: 15196549
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T, Kunisaki C, Yoshihara K, Yamada R, Yamamoto N, Sato T, Makino H, Yamagishi S, Nagano Y, Fujii S, Shiozawa M, Akaike M, Wada N, Rino Y, Masuda M, Tanaka K, Imada T.
    Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
    [Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.
    Span PN, Sweep CG, Manders P, Beex LV, Leppert D, Lindberg RL.
    Cancer; 2003 Jun 01; 97(11):2710-5. PubMed ID: 12767082
    [Abstract] [Full Text] [Related]

  • 6. Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
    Song SY, Son HJ, Nam E, Rhee JC, Park C.
    Eur J Cancer; 2006 Jan 01; 42(1):101-8. PubMed ID: 16324834
    [Abstract] [Full Text] [Related]

  • 7. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T, Hisanaga M, Nagao M, Ikeda N, Fujii H, Koyama F, Mukogawa T, Matsumoto H, Kondo S, Takahashi C, Noda M, Nakajima Y.
    Clin Cancer Res; 2004 Aug 15; 10(16):5572-9. PubMed ID: 15328199
    [Abstract] [Full Text] [Related]

  • 8. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.
    Kang HG, Kim HS, Kim KJ, Oh JH, Lee MR, Seol SM, Han I.
    J Orthop Res; 2007 May 15; 25(5):696-702. PubMed ID: 17262820
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.
    Takenaka K, Ishikawa S, Yanagihara K, Miyahara R, Hasegawa S, Otake Y, Morioka Y, Takahashi C, Noda M, Ito H, Wada H, Tanaka F.
    Ann Surg Oncol; 2005 Oct 15; 12(10):817-24. PubMed ID: 16132376
    [Abstract] [Full Text] [Related]

  • 10. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
    Liu LT, Chang HC, Chiang LC, Hung WC.
    Cancer Res; 2003 Jun 15; 63(12):3069-72. PubMed ID: 12810630
    [Abstract] [Full Text] [Related]

  • 11. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
    Masui T, Doi R, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Koizumi M, Toyoda E, Tulachan S, Ito D, Kami K, Mori T, Wada M, Noda M, Imamura M.
    Clin Cancer Res; 2003 May 15; 9(5):1779-84. PubMed ID: 12738734
    [Abstract] [Full Text] [Related]

  • 12. RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs.
    Furumoto K, Arii S, Mori A, Furuyama H, Gorrin Rivas MJ, Nakao T, Isobe N, Murata T, Takahashi C, Noda M, Imamura M.
    Hepatology; 2001 Jan 15; 33(1):189-95. PubMed ID: 11124835
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.
    Cho YB, Lee WY, Song SY, Shin HJ, Yun SH, Chun HK.
    Hum Pathol; 2007 Nov 15; 38(11):1603-10. PubMed ID: 17669467
    [Abstract] [Full Text] [Related]

  • 14. Expression of membrane-anchored matrix metalloproteinase inhibitor reversion inducing cysteine rich protein with Kazal motifs in murine cell lines.
    Takagi S, Hoshino Y, Osaki T, Okumura M, Fuginaga T.
    Exp Oncol; 2007 Mar 15; 29(1):30-4. PubMed ID: 17431385
    [Abstract] [Full Text] [Related]

  • 15. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells.
    Liu LT, Chang HC, Chiang LC, Hung WC.
    Oncogene; 2002 Nov 28; 21(54):8347-50. PubMed ID: 12447698
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
    Correa TC, Brohem CA, Winnischofer SM, da Silva Cardeal LB, Sasahara RM, Taboga SR, Sogayar MC, Maria-Engler SS.
    J Cell Biochem; 2006 Sep 01; 99(1):156-67. PubMed ID: 16791855
    [Abstract] [Full Text] [Related]

  • 17. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.
    Asano T, Tada M, Cheng S, Takemoto N, Kuramae T, Abe M, Takahashi O, Miyamoto M, Hamada J, Moriuchi T, Kondo S.
    J Surg Res; 2008 May 01; 146(1):32-42. PubMed ID: 17543340
    [Abstract] [Full Text] [Related]

  • 18. Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma.
    Xu J, Wu S, Shi X.
    J Orthop Res; 2010 Dec 01; 28(12):1621-5. PubMed ID: 20973064
    [Abstract] [Full Text] [Related]

  • 19. Dual effects of the membrane-anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cells.
    Kondo S, Shukunami C, Morioka Y, Matsumoto N, Takahashi R, Oh J, Atsumi T, Umezawa A, Kudo A, Kitayama H, Hiraki Y, Noda M.
    J Cell Sci; 2007 Mar 01; 120(Pt 5):849-57. PubMed ID: 17298979
    [Abstract] [Full Text] [Related]

  • 20. Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells.
    Cho CY, Wang JH, Chang HC, Chang CK, Hung WC.
    J Cell Physiol; 2007 Oct 01; 213(1):65-9. PubMed ID: 17443689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.